newsfilter
← Latest News
GlobeNewswire·

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

RAMSEY, N.J. and BOCA RATON, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing,